Literature DB >> 15177782

Campath-1H treatment of multiple sclerosis: lessons from the bedside for the bench.

Alasdair Coles1, Jackie Deans, Alastair Compston.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15177782     DOI： 10.1016/j.clineuro.2004.02.013

Source DB:  PubMed          Journal:  Clin Neurol Neurosurg        ISSN： 0303-8467            Impact factor:   1.876


× No keyword cloud information.
  20 in total

1.  Three cases of alopecia following clinical islet transplantation.

Authors:  D M Zuk; A Koh; S Imes; A M J Shapiro; P A Senior
Journal:  Am J Transplant       Date:  2011-01       Impact factor: 8.086

2.  Tolerogen-induced interferon-producing killer dendritic cells (IKDCs) protect against EAE.

Authors:  Eduardo Huarte; Agnieszka Rynda-Apple; Carol Riccardi; Jerod A Skyberg; Sarah Golden; Maryclare F Rollins; Andrew G Ramstead; Larissa O Jackiw; Massimo Maddaloni; David W Pascual
Journal:  J Autoimmun       Date:  2011-10-22       Impact factor: 7.094

3.  Monoclonal antibodies and progressive multifocal leukoencephalopathy.

Authors:  Joseph R Berger; Sidney A Houff; Eugene O Major
Journal:  MAbs       Date:  2009 Nov-Dec       Impact factor: 5.857

Review 4.  Infections in Patients Receiving Multiple Sclerosis Disease-Modifying Therapies.

Authors:  Elena Grebenciucova; Amy Pruitt
Journal:  Curr Neurol Neurosci Rep       Date:  2017-09-22       Impact factor: 5.081

5.  [Alemtuzumab: a further option for treatment of multiple sclerosis].

Authors:  T Menge; B C Kieseier; C Warnke; O Aktas; H-P Hartung
Journal:  Nervenarzt       Date:  2012-04       Impact factor: 1.214

6.  [Alemtuzumab for relapsing-remitting multiple sclerosis. Results of two randomized controlled phase III studies].

Authors:  L Klotz; S G Meuth; B Kieseier; H Wiendl
Journal:  Nervenarzt       Date:  2013-08       Impact factor: 1.214

7.  Campath 1-H treatment in patients with aggressive relapsing remitting multiple sclerosis.

Authors:  C L Hirst; A Pace; T P Pickersgill; R Jones; B N McLean; J P Zajicek; N J Scolding; N P Robertson
Journal:  J Neurol       Date:  2008-02-20       Impact factor: 4.849

8.  Examination of the role of magnetic resonance imaging in multiple sclerosis: A problem-orientated approach.

Authors:  Henry F McFarland
Journal:  Ann Indian Acad Neurol       Date:  2009-10       Impact factor: 1.383

9.  Management of secondary progressive multiple sclerosis: prophylactic treatment-past, present, and future aspects.

Authors:  Paulus S Rommer; Olaf Stüve
Journal:  Curr Treat Options Neurol       Date:  2013-06       Impact factor: 3.598

Review 10.  New developments in understanding and treating neuroinflammation.

Authors:  C Infante-Duarte; S Waiczies; J Wuerfel; F Zipp
Journal:  J Mol Med (Berl)       Date:  2008-01-15       Impact factor: 4.599
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.